XML 38 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 912,814 $ 713,656
Accounts receivable, net 321,258 284,292
Inventory 68,025 64,029
Other current assets 24,536 16,683
Assets held for sale 0 7,159
Total current assets 1,326,633 1,085,819
Investment in equity securities 39,489 0
Property, plant and equipment, net 176,798 146,697
Intangibles, net 161,761 151,985
Goodwill 61,189 61,189
Deferred tax assets, net 170,233 150,198
Other long-term assets 44,237 55,261
Total assets 1,980,340 1,651,149
Current liabilities    
Current portion of long-term debt and other borrowings 974 823
Accounts payable 34,560 41,189
Accrued expenses and other liabilities 204,992 145,338
Total current liabilities 240,526 187,350
Asset retirement obligations 23,344 22,916
Long-term debt, net and other borrowings 565,279 561,670
Other long-term liabilities 63,180 63,321
Total liabilities 892,329 835,257
Commitments and contingencies (see Note 19)
Stockholders’ equity    
Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding) 0 0
Common stock ($0.01 par value, 250,000 shares authorized; 70,905 and 69,863 shares issued and outstanding as of December 31, 2024 and 2023, respectively) 709 699
Additional paid-in capital 817,972 757,727
Treasury Stock at cost - 2,455 shares and 1,339 shares as of December 31, 2024 and 2023, respectively (175,000) (75,000)
Retained earnings 445,945 133,503
Accumulated other comprehensive loss (1,615) (1,037)
Total stockholders’ equity 1,088,011 815,892
Total liabilities and stockholders’ equity $ 1,980,340 $ 1,651,149